NSE: DIVISLAB

DIVISLAB: Navigating Geopolitical Storms and Biopharma Winds

By StreetVantage Intelligence // March 29, 2026

₹₹5,997.50

NEUTRAL

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.